We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TNYA market cap is 276.38M. The company's latest EPS is USD -1.5803 and P/E is -2.23.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -33.72M | -35.1M | -30.92M | -31.45M | -33.76M |
| Net Income | -31.74M | -33.27M | -29.14M | -29.94M | -32.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.71M | -38.91M | -72.81M | -125.62M | -131.19M |
| Net Income | -26.23M | -38.4M | -72.72M | -123.67M | -124.08M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 245.34M | 220.75M | 193.4M | 170.52M | 184.9M |
| Total Liabilities | 29.93M | 30.81M | 28.51M | 31.09M | 26.72M |
| Total Equity | 215.41M | 189.94M | 164.88M | 139.42M | 158.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 38M | 148.16M | 314.19M | 278.95M | 170.52M |
| Total Liabilities | 8.7M | 8.72M | 35.66M | 35.57M | 31.09M |
| Total Equity | -43.74M | -81.32M | 278.53M | 243.38M | 139.42M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.29M | -56.51M | -80.15M | -102.07M | -28.66M |
| Investing | 8.06M | 33.15M | 63.63M | 48.72M | -4.49M |
| Financing | -501k | 3.68M | 3.68M | 4.05M | 46.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -24.1M | -35.45M | -60.81M | -104.42M | -102.07M |
| Investing | -5.58M | -7.01M | -238.56M | 83.65M | 48.72M |
| Financing | 30.51M | 147.27M | 208.97M | 77.77M | 4.05M |
| Market Cap | 276.38M |
| Price to Earnings Ratio | -2.23 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.05 |
| Price to Book Ratio | 1.98 |
| Dividend Yield | - |
| Shares Outstanding | 78.52M |
| Average Volume (1 week) | 268.45k |
| Average Volume (1 Month) | 540.11k |
| 52 Week Change | -36.46% |
| 52 Week High | 7.01 |
| 52 Week Low | 1.66 |
| Spread (Intraday) | 0.67 (16.88%) |
| Company Name | Tenaya Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.tenayatherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
